Daily BriefsECM

Daily Brief ECM: SIA Placement – Selldown Isn’t Particularly Well Flagged. Overhang Is Too Large to Ignore and more

In today’s briefing:

  • SIA Placement – Selldown Isn’t Particularly Well Flagged. Overhang Is Too Large to Ignore
  • Tryt IPO – Peer Comp – One of the Widest Margins Historically, but Has Lagged over the Track Record
  • Kelun-Biotech (科伦博泰) IPO: Fairly Valued at Best
  • Mobvoi IPO: Right Decision at the Right Time
  • TRYT IPO: The Bear Case
  • Redox IPO Trading – Peers Have Mostly Corrected over the past Month


SIA Placement – Selldown Isn’t Particularly Well Flagged. Overhang Is Too Large to Ignore

By Clarence Chu

  • Napier (Temasek) is looking to raise around US$300m via its secondary selldown in Singapore Airlines (SIA SP).
  • The deal isn’t very well flagged given that the investor hadn’t earlier given any explicit guidance of a selldown. 
  • Post-Selldown, Temasek will still own over 50% of SIA’s shares outstanding, so the overhang will be a large one.

Tryt IPO – Peer Comp – One of the Widest Margins Historically, but Has Lagged over the Track Record

By Clarence Chu

  • Tryt Inc (9164 JP) is looking to raise about US$460m in its Japan IPO.
  • Tryt Inc (Tryt) offers employee placement services and temporary staffing services for the elderly care, nursing care and childcare workers segments.
  • We have looked at the company’s past performance in our earlier notes, in this note we will undertake a peer comparison.

Kelun-Biotech (科伦博泰) IPO: Fairly Valued at Best

By Ke Yan, CFA, FRM

  • Kelun-Biotech is a China-based integrated innovative biopharmaceutical company. The company launched a deal to  raise up to US$200m via a Hong Kong listing.
  • In our previous note, we looked at the company’s product lines and provided a brief overview on the company’s valuation.
  • In this note, we provide an update for the book building. We provide our quick thoughts on the valuation and deal dynamics.

Mobvoi IPO: Right Decision at the Right Time

By Shifara Samsudeen, ACMA, CGMA

  • Mobvoi is a leading AI company with generative AI and voice interaction technologies at the core of its business. The company has filed for an IPO on the HKEx.
  • Unlike a lot of the AI start-ups, Mobvoi has already begun commercialising its products and services and the company has started generating operating profits in 2022.
  • The advent of ChatGPT and Midjourney have created a hype for AI. Mobvoi has taken the right decision to go public at the right time.

TRYT IPO: The Bear Case

By Arun George

  • Tryt Inc (9164 JP), a leading professional recruiting and temporary staffing service in Japan, seeks to raise US$450 million. Pricing is on 5 July, and book-building is 6-11 July. 
  • In TRYT IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The key elements of the bear case rest on mid-tier revenue growth rates, margin pressure led by rising labour expenses, bottom-tier FCF margin and high leverage.

Redox IPO Trading – Peers Have Mostly Corrected over the past Month

By Sumeet Singh

  • Redox (RDX AU), a chemical and ingredients distributor, raised around US$270m in its Australia IPO. The stock will begin to trade on 3rd July 2023.
  • In 2022 it was ranked as the largest chemicals and ingredients distributor in Australia, as well as the 13th largest in the Asia Pacific region and the 35th largest worldwide
  • We have looked at the company’s past performance in our previous note, in this note we will talk about the updates since then and the trading dynamics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars